1. Home
  2. CRI vs EVO Comparison

CRI vs EVO Comparison

Compare CRI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$33.21

Market Cap

1.3B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.41

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
EVO
Founded
1865
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
CRI
EVO
Price
$33.21
$3.41
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$34.00
$7.00
AVG Volume (30 Days)
1.0M
144.4K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$2,844,102,000.00
N/A
Revenue This Year
$2.49
N/A
Revenue Next Year
$0.21
$7.13
P/E Ratio
$56.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.38
$2.84
52 Week High
$44.44
$4.80

Technical Indicators

Market Signals
Indicator
CRI
EVO
Relative Strength Index (RSI) 35.74 45.57
Support Level $28.71 $3.40
Resistance Level $33.53 $3.78
Average True Range (ATR) 1.92 0.09
MACD -0.44 -0.03
Stochastic Oscillator 5.63 22.97

Price Performance

Historical Comparison
CRI
EVO

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: